What is included in this Sample?
- * Market Segmentation
- * Key Findings
- * Research Scope
- * Table of Content
- * Report Structure
- * Report Methodology
Download FREE Sample Report
Dental Sleep Medicine Market Size, Share, Growth, and Industry Analysis, By Type (Diagnostic Device and Treatment Device), By Application (Hospitals, Clinics and Others), Regional Outlook, and Forecast From 2025 To 2033
Trending Insights

Global Leaders in Strategy and Innovation Rely on Our Expertise to Seize Growth Opportunities

Our Research is the Cornerstone of 1000 Firms to Stay in the Lead

1000 Top Companies Partner with Us to Explore Fresh Revenue Channels
Dental Sleep Medicine Market Overview
The global dental sleep medicine market size was valued at approximately USD 7.78 billion in 2024 and is expected to reach USD 15.84 billion by 2033, growing at a compound annual growth rate (CAGR) of about 5.57% from 2025 to 2033.
Dental sleep medicine is a branch of dentistry that uses oral appliances like positive airway pressure (PAP) devices, nasal masks, and airway systems, as well as medications like Provigil (modafinil) and Nuvigil, to treat sleep-related breathing disorders like snoring, upper airway resistance syndrome (UARS), bruxism, and sleep apnea (armodafinil). The increasing prevalence of sleep apnea is the main factor driving the global market for dental sleep medications upward. The rapidly rising global awareness of sleep problems is one of the key factors boosting the market for dental sleep medicine market boosting demand.
The rapid rise in illnesses and the rising older population are both fuelling the expansion of the global market. The industry is also being driven forward by quick technological developments and the global rise in sleep apnea cases. One of the main factors driving the growth of the sleep dental medicine sector is a better understanding of the long-term effects of obstructive sleep apnea.
COVID-19 Impact: Significant Impact on Market Trends for Dental Sleep Medicine Market Affected the Development
The global COVID-19 pandemic has been unprecedented and staggering, with the industrial embroidery machine market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden spike in CAGR is attributable to the market's growth and demand returning to pre-pandemic levels once the pandemic is over.
The World Health Organization has declared a public health emergency as a result of the disease's global expansion since the COVID-19 virus first appeared. The coronavirus infection (COVID-19) is already having an influence on the world, and it will have a significant impact on market trends for dental sleep medicine. The COVID-19 epidemic has caused several supply chain disruptions, flight cancellations, quarantines, restaurant closures, prohibitions on all indoor and outdoor events, over forty countries declaring states of emergency, and stock market instability.
Latest Trends
Unmet Medical Needs and Rise of Geriatric People in Some Region to Increase Market Growth
The global market for dental sleep medicine is anticipated to expand over the assessment period. some of the market trends and factors in this market include the increasing prevalence of sleep apnea on a global scale, unmet medical needs, a rise in the number of geriatric people, adoption of cutting-edge innovative technologies, and an increase in the prevalence of lifestyle-related diseases like obesity and cardiovascular disease.
Dental Sleep Medicine Market Segmentation
- By Type Analysis
According to type, the dental sleep medicine market can be segmented into Diagnostic Device and Treatment Device.
In terms of type, the Diagnostic Device is anticipated to be the largest segment during the forecast period.
- By Application Analysis
Based on application, the dental sleep medicine market can be divided into Hospitals, Clinics and Others.
In terms of application, Hospitals market is projected to hold the largest market share through 2028.
Driving Factors
People are Becoming Aware of the Risks of Untreated Sleep Apnea Will Rise Market Growth
people are becoming more aware of the financial effects of untreated sleep apnea. If left untreated, obstructive sleep apnea (OSA) is a dangerous condition that can seriously harm the heart. Long-term untreated sleep apnea can also result in several linked illnesses, including congestive heart failure, type 2 diabetes, stroke, other sleep disorders, cognitive and memory deficits, and cardiovascular disease or even congestive heart failure. Healthcare industry participants are encouraged by growing knowledge of the financial costs associated with untreated sleep apnea.
Complicated Referral Processes to Uplift Market Demand
For the appropriate diagnosis and subsequent treatment of OSA, the referral pathway from primary care physicians (PCPs) to sleep specialists, then to Durable Medical Equipment (DME) divisions, home healthcare dealers, or dentistry practitioners, frequently generates bottlenecks. Most patients lose hope before reaching a sleep specialist because they lack the patience to endure such drawn-out referral procedures. This could potentially result in a delayed diagnosis. Other obstacles to the accurate diagnosis and therapy of sleep apnea include a dearth of dental experts, a lack of education and awareness among dentists and primary care physicians, and a significant lack of sleep clinics with the necessary equipment. This factor will potentially grow the market.
Restraining Factors
Alternative Treatments and Prescription Drugs are a Major Impediment To Market Expansion
Positive airway pressure therapy is the initial line of treatment for sleep apnea, however patient compliance can be difficult. Because it may be uncomfortable to endure and compliance with these devices regularly declines, patients seek alternatives to traditional PAP therapy such as expiratory positive airway pressure (EPAP), hypoglossal nerve stimulation, oral pressure therapy (OPT), and positional therapy. While there are other medicinal methods used to treat sleep apnea.
-
Request a Free sample to learn more about this report
Dental Sleep Medicine Market Regional Insights
North America Region is Dominating market Due to High Per Capita Income
North America, make up the global dental sleep medicine market share in the regions. The biggest market for dental sleep medicine was in North America. It dominates market because to its high per capita income, superior medical equipment reimbursement rules, and larger healthcare sector. The concentration of significant medical device manufacturers in the U.S. is another factor driving the growth of the North American market.
Key Industry Players
Adoption Experiential Marketing Services by Key Players Influencing Market Development
The top key players in the market such as Curative Medical, BMC Medical, Apex Medical Corporation, ResMed, Drive DeVilbiss Healthcare, Fisher & Paykel Healthcare. Most of the top players hold the experiential marketing service market shares. In addition, the strategies to develop new technologies, capital investment in R&D, improve product quality, acquisitions, mergers, and compete for the dental sleep medicine market growth in the competition help them to perpetuate their position and value in the market. Besides, collaboration with other companies & extensive possession over market shares by the key players stimulates the dental sleep medicine market.
LIST OF TOP DENTAL SLEEP MEDICINE COMPANIES
- Curative Medical (U.S.)
- BMC Medical (China)
- Apex Medical Corporation (China)
- ResMed (U.S.)
- Drive DeVilbiss Healthcare (U.S.)
- Fisher & Paykel Healthcare (New Zealand)
- BD (U.S.)
- Koninklijke Philips (Netherlands)
Report Coverage
This report examines an understanding of the dental sleep medicine market’s size, share, growth rate, segmentation by type, application, key players, and previous and current market scenarios. The report also collects the market’s precise data and forecasts by market experts. Also, it describes the study of this industry’s financial performance, investments, growth, innovation marks, and new product launches by the top companies and offers deep insights into the current market structure, competitive analysis based on key players, key driving forces, and restraints that affect the demand for growth, opportunities, and risks.
Furthermore, the post-COVID-19 pandemic’s effects on international market restrictions and a deep understanding of how the industry will recover, and strategies are also stated in the report. The competitive landscape has also been examined in detail to provide clarification of the competitive landscape.
This report also discloses the research based on methodologies that define price trend analysis of target companies, collection of data, statistics, target competitors, import-export, information, and previous years’ records based on market sales. Moreover, all the significant factors which influence the market such as small or medium business industry, macro-economic indicators, value chain analysis, and demand-side dynamics, with all the major business players have been explained in detail. This analysis is subject to modification if the key players and feasible analysis of market dynamics change.
Attributes | Details |
---|---|
Market Size Value In |
US$ 6140.77 Million in 2021 |
Market Size Value By |
US$ 14640.17 Million by 2032 |
Growth Rate |
CAGR of 8.22% from 2024 to 2032 |
Forecast Period |
2024-2032 |
Base Year |
2024 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
|
By Types
|
|
By Application
|
FAQs
The global dental sleep medicine market is expected to touch USD 14640.17 million by 2032.
The global dental sleep medicine market is expected to exhibit a CAGR of 8.22% over 2024-2032.
More People Become Aware of the Risks of Untreated Sleep Apnea is the driving factor of the dental sleep medicine market.
Curative Medical, BMC Medical, Apex Medical Corporation, ResMed, Drive DeVilbiss Healthcare, Fisher & Paykel Healthcare are the top operating companies in the dental sleep medicine market.